PortfoliosLab logo

Axsome Therapeutics, Inc. (AXSM)

Equity · Currency in USD · Last updated Dec 9, 2022

Company Info

ISINUS05464T1043
CUSIP05464T104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$77.85
Year Range$21.74 - $78.16
EMA (50)$58.89
EMA (200)$46.28
Average Volume$1.57M
Market Capitalization$3.38B

AXSMShare Price Chart


Loading data...

AXSMPerformance

The chart shows the growth of $10,000 invested in Axsome Therapeutics, Inc. in Nov 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $89,073 for a total return of roughly 790.73%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%200.00%JulyAugustSeptemberOctoberNovemberDecember
219.72%
1.61%
AXSM (Axsome Therapeutics, Inc.)
Benchmark (^GSPC)

AXSMCompare to other instruments

Search for stocks, ETFs, and funds to compare with AXSM

AXSMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M37.01%4.12%
6M181.35%-3.70%
YTD106.06%-16.84%
1Y127.76%-15.43%
5Y74.56%8.39%
10Y36.41%9.58%

AXSMMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-27.37%2.44%47.24%-23.29%-21.26%53.20%0.76%65.33%-30.06%1.19%60.11%7.69%
2021-16.42%-1.07%-15.94%6.78%0.41%11.12%-27.97%-47.15%28.35%16.81%-10.29%9.38%
2020-16.00%-10.16%-24.58%61.53%-18.99%6.88%-13.31%2.78%-2.81%-6.93%9.32%12.39%
2019197.52%-5.13%78.77%24.60%29.50%12.15%-0.97%-0.20%-20.47%18.97%63.50%162.53%
2018-50.00%-8.93%-3.92%38.78%-1.47%-4.48%-17.97%31.43%0.00%12.17%-15.76%-13.50%
2017-27.41%-7.14%-14.29%5.13%-6.10%42.86%10.91%-16.39%8.82%-14.41%18.95%-0.88%
2016-15.53%-0.77%10.68%33.14%-31.44%-3.95%3.71%-7.42%8.84%-14.97%-2.24%3.05%
20151.03%4.98%

AXSMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Axsome Therapeutics, Inc. Sharpe ratio is 1.06. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
1.06
-0.65
AXSM (Axsome Therapeutics, Inc.)
Benchmark (^GSPC)

AXSMDividend History


Axsome Therapeutics, Inc. doesn't pay dividends

AXSMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-26.72%
-17.37%
AXSM (Axsome Therapeutics, Inc.)
Benchmark (^GSPC)

AXSMWorst Drawdowns

The table below shows the maximum drawdowns of the Axsome Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Axsome Therapeutics, Inc. is 86.65%, recorded on Dec 27, 2018. It took 59 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.65%Jan 6, 2016750Dec 27, 201859Mar 25, 2019809
-81.26%Dec 27, 2019415Aug 19, 2021
-42.7%Sep 17, 201911Oct 1, 201935Nov 19, 201946
-17.63%Mar 26, 201914Apr 12, 20198Apr 25, 201922
-17.48%Jul 29, 201914Aug 15, 201921Sep 16, 201935
-17.26%May 29, 201910Jun 11, 20197Jun 20, 201917
-11.38%Jun 21, 20194Jun 26, 20191Jun 27, 20195
-10.33%Nov 25, 201513Dec 14, 201510Dec 29, 201523
-9.37%Jul 3, 201912Jul 19, 20195Jul 26, 201917
-8.83%Dec 5, 20191Dec 5, 20193Dec 10, 20194

AXSMVolatility Chart

Current Axsome Therapeutics, Inc. volatility is 152.68%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%JulyAugustSeptemberOctoberNovemberDecember
152.68%
23.44%
AXSM (Axsome Therapeutics, Inc.)
Benchmark (^GSPC)